WS-015

N/A

Report date: 2022/07/14 09:49:17
NME

Base Information

Drug NameWS-015
Drug Alias NameWS-015
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperuricemiaGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWaterstone Pharmaceuticals (Wuhan) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesWaterstone Pharmaceuticals (Wuhan) Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperuricemiaGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A